CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RARE

aceneuramic acid extended-release (Ace-ER)

Phase 3
Ultragenyx Pharmaceutical Inc. (RARE)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Hereditary Inclusion Body Myopathy

View Full Landscape
Drug Information

Target Indication

Hereditary Inclusion Body Myopathy

Clinical Trial

NCT02377921

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.